SESEN BIO INC (SESN)

US8177631053 - Common Stock

0.6288  +0.04 (+7.29%)

After market: 0.5832 -0.05 (-7.25%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

SESEN BIO INC

NASDAQ:SESN (3/7/2023, 6:50:19 PM)

After market: 0.5832 -0.05 (-7.25%)

0.6288

+0.04 (+7.29%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap127.96M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

SESN Daily chart

Company Profile

Sesen Bio, Inc. engages in designing, engineering, and developing targeted protein therapeutics. The company is headquartered in Cambridge, Massachusetts and currently employs 35 full-time employees. The company went IPO on 2014-02-06. The firm's product candidates are based on its TFPT platform and are focused on addressing areas of unmet medical need in cancer. TFPTs are single protein therapeutics composed of targeting domains genetically fused via peptide linkers to cytotoxic protein payloads that are produced through its recombinant one-step, microbial manufacturing process. The Company’s advanced product candidate Vicinium, also known as VB4-845, which is composed of an anti-epithelial cell adhesion molecule (EpCAM) antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of bacillus calmette-guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC).

Company Info

SESEN BIO INC

245 1st St Ste 1800

Cambridge MASSACHUSETTS 02142

P: 16174448550.0

CEO: Thomas R. Cannell

Employees: 35

Website: https://sesenbio.com/

SESN News

News Imagea year ago - Seeking AlphaSesen Bio stockholders approve 1-for-20 reverse stock split (NASDAQ:SESN)

Sesen Bio (SESN) stockholders on Thursday approved effecting a 1-for-20 reverse stock split of the company's issued and outstanding shares. Read more here.

News Imagea year ago - Seeking AlphaSesen Bio wins shareholder approval for Carisma merger (NASDAQ:SESN)

Sesen Bio (SESN) announced Thursday that its shareholders greenlighted the company’s pending merger with Carisma Therapeutics at a special stockholder meeting. Read the full story here.

News Imagea year ago - Sesen Bio, Inc.Sesen Bio Stockholders Approve Merger with Carisma Therapeutics
News Imagea year ago - Sesen Bio, Inc.Sesen Bio Reports Fourth Quarter and Full-Year 2022 Financial Results
News Imagea year ago - Weiss LawSHAREHOLDER ALERT: Weiss Law Reminds SESN, MLVF, VLON, and SHBI Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

News Imagea year ago - Sesen Bio, Inc.Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS in Recommending That Sesen Bio Stockholders Vote “FOR” All Proposals to Approve Pending Merger With Carisma

SESN Twits

Here you can normally see the latest stock twits on SESN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example